What does APOTHEEK SWIJZEN do?

APOTHEEK SWIJZEN is a pharmacy in Herentals. Private Limited, started on 4 May 1984, 1 establishment.

What is the address of APOTHEEK SWIJZEN?

The registered office of APOTHEEK SWIJZEN is located at Ring(NDW) 35, 2200 Herentals.

Is APOTHEEK SWIJZEN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK SWIJZEN is active, legal situation “Normale toestand”, started on 4 May 1984.

Is APOTHEEK SWIJZEN registered on Peppol?

Yes, APOTHEEK SWIJZEN is registered on the Peppol network with ID 0208:0425798524.

What is the enterprise number of APOTHEEK SWIJZEN?

The enterprise number of APOTHEEK SWIJZEN is BE0425798524.

When was APOTHEEK SWIJZEN founded?

APOTHEEK SWIJZEN was founded on 4 May 1984.

Who are the directors of APOTHEEK SWIJZEN?

According to the 2025 annual accounts, the directors of APOTHEEK SWIJZEN are: LIEVE SWIJZEN, HSM NV, Astrid Hellings, Hendrik Hellings, Heleen Hellings.

Is APOTHEEK SWIJZEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 May 1984; 5 annual accounts filed, latest fiscal year 2025; 5 directors known from the annual account.

How much profit did APOTHEEK SWIJZEN make in 2025?

APOTHEEK SWIJZEN recorded a loss after taxes of € 91,956 in financial year 2025.

What is the revenue of APOTHEEK SWIJZEN?

As a small company, APOTHEEK SWIJZEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 279,775.

Does APOTHEEK SWIJZEN have a website?

Yes, APOTHEEK SWIJZEN has a website at apotheekswijzen.be.

APOTHEEK SWIJZEN (Private Limited) - Herentals

Dossier APOTHEEK SWIJZEN, printed on 30 October 2026 from databakkes.be/en/0425798524/apotheek-swijzen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 2 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK SWIJZEN from Herentals, company number BE0425798524, closed financial year 2025 with a result of € -91,956 after tax. For that financial year APOTHEEK SWIJZEN recorded a gross margin of € 279,775 and equity of € -139,136. Compared with financial year 2024, the result moved from € -122,942 to € -91,956. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.

What it is worth Caution

€ -139,136

▼ € 91,956 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -91,956

▲ 25 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 198,571

▲ 93% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -157,736.

People and assets in 2025

Wage cost

€ 219,768

▼ 12% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 526,094

▼ 10% vs 2024

Of which on lease € 520,770.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 457,583

▼ 19% vs 2024

€ 94,516 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 135,921

▼ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 33,952

▲ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 346,390 Gross margin 2022: € 346,390 First fiscal year in the series	€ 382,250 Gross margin 2023: € 382,250 ▲ 10% vs 2022 (€ 346,390) Favourable step	€ 277,122 Gross margin 2024: € 277,122 ▼ 28% vs 2023 (€ 382,250) Unfavourable step	€ 279,775 Gross margin 2025: € 279,775 ▲ 1% vs 2024 (€ 277,122) Favourable step	▲ 1%
Profit after taxes	€ -97,291 Profit after taxes 2022: € -97,291 First fiscal year in the series	€ -918 Profit after taxes 2023: € -918 ▲ € 96,373 vs 2022 (€ -97,291) Favourable step	€ -122,942 Profit after taxes 2024: € -122,942 ▼ € 122,024 vs 2023 (€ -918) Unfavourable step	€ -91,956 Profit after taxes 2025: € -91,956 ▲ € 30,986 vs 2024 (€ -122,942) Favourable step	▲ € 30,986
Equity	€ 76,680 Equity 2022: € 76,680 First fiscal year in the series	€ 75,762 Equity 2023: € 75,762 ▼ 1% vs 2022 (€ 76,680) Unfavourable step	€ -47,180 Equity 2024: € -47,180 ▼ € 122,942 vs 2023 (€ 75,762) Unfavourable step	€ -139,136 Equity 2025: € -139,136 ▼ € 91,956 vs 2024 (€ -47,180) Unfavourable step	▼ € 91,956
Total debts	€ 1,446,932 Total debts 2022: € 1,446,932 First fiscal year in the series	€ 1,316,949 Total debts 2023: € 1,316,949 ▼ 9% vs 2022 (€ 1,446,932) Favourable step	€ 1,594,592 Total debts 2024: € 1,594,592 ▲ 21% vs 2023 (€ 1,316,949) Unfavourable step	€ 1,349,503 Total debts 2025: € 1,349,503 ▼ 15% vs 2024 (€ 1,594,592) Favourable step	▼ 15%
Cash	€ 127,738 Cash 2022: € 127,738 First fiscal year in the series	€ 154,322 Cash 2023: € 154,322 ▲ 21% vs 2022 (€ 127,738) Favourable step	€ 102,862 Cash 2024: € 102,862 ▼ 33% vs 2023 (€ 154,322) Unfavourable step	€ 198,571 Cash 2025: € 198,571 ▲ 93% vs 2024 (€ 102,862) Favourable step	▲ 93%
Land & buildings	-	-	€ 66,336 Land & buildings 2024: € 66,336 First fiscal year in the series	€ 61,528 Land & buildings 2025: € 61,528 ▼ 7% vs 2024 (€ 66,336) Unchanged	▼ 7%
Retained profit	€ 58,080 Retained profit 2022: € 58,080 First fiscal year in the series	€ 57,162 Retained profit 2023: € 57,162 ▼ 2% vs 2022 (€ 58,080) Unfavourable step	€ -65,780 Retained profit 2024: € -65,780 ▼ € 122,942 vs 2023 (€ 57,162) Unfavourable step	€ -157,736 Retained profit 2025: € -157,736 ▼ € 91,956 vs 2024 (€ -65,780) Unfavourable step	▼ € 91,956
Bank debt	€ 710,050 Bank debt 2022: € 710,050 First fiscal year in the series	€ 686,821 Bank debt 2023: € 686,821 ▼ 3% vs 2022 (€ 710,050) Favourable step	€ 564,182 Bank debt 2024: € 564,182 ▼ 18% vs 2023 (€ 686,821) Favourable step	€ 457,583 Bank debt 2025: € 457,583 ▼ 19% vs 2024 (€ 564,182) Favourable step	▼ 19%
Balance sheet total	€ 1,526,230 Balance sheet total 2022: € 1,526,230 First fiscal year in the series	€ 1,394,996 Balance sheet total 2023: € 1,394,996 ▼ 9% vs 2022 (€ 1,526,230) Unchanged	€ 1,549,364 Balance sheet total 2024: € 1,549,364 ▲ 11% vs 2023 (€ 1,394,996) Unchanged	€ 1,211,985 Balance sheet total 2025: € 1,211,985 ▼ 22% vs 2024 (€ 1,549,364) Unchanged	▼ 22%

Key figures of APOTHEEK SWIJZEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SWIJZEN?

What happened at APOTHEEK SWIJZEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 7, 2026 New annual accounts for financial year 2025: loss of € 91,956. filed late Source: NBB ↗
Jul 1, 1984 New establishment in Herentals. KBO
May 4, 1984 Start of the company according to the CBE. KBO

In short

From € 97,291 loss in 2022 to € 91,956 loss in 2025.

Original PDFs at the National Bank ↗

Management

H.S.M. 99%

The stake of H.S.M. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK SWIJZEN

Behind APOTHEEK SWIJZEN are LIEVE SWIJZEN, HSM NV, Astrid Hellings, Hendrik Hellings and Heleen Hellings. The shares are held by H.S.M. (99%).

Directors

According to the 2025 annual accounts

LIEVE SWIJZEN

Administrator-manager

Also active at: APOTHEEK HELLINGS AALST NV, APOTHEEK HELLINGS

HSM NV

Manager · represented by Lieve Swijzen

Also active at: APOTHEEK HELLINGS AALST NV, APOTHEEK HELLINGS

Astrid Hellings

Director

Also active at: APOTHEEK HELLINGS AALST NV, APOTHEEK HELLINGS, H.S.M.

Hendrik Hellings

Director

Also active at: APOTHEEK HELLINGS AALST NV, APOTHEEK HELLINGS, H.S.M.

Heleen Hellings

Director

Also active at: APOTHEEK HELLINGS AALST NV, APOTHEEK HELLINGS, H.S.M.

Shareholders

H.S.M.

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Ring(NDW) 35

2200 Herentals

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekswijzen.be

About

Technologies

Alpine.jsApacheBunny CDNFont AwesomeGoogle FontsSwiperreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

AMAZON-02 - Amazon.com, Inc., US

Website info

HTTPS Ja

Languages NL

Features

Webshop Blog Client portal Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ Load balancing

Details

Company number

0425.798.524

VAT number

BE 0425.798.524

Registered office

Ring(NDW) 35, 2200 Herentals

Names & denominations

APOTHEEK SWIJZEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 May 1984

Peppol

Active · Active since 19 Dec 2025

Contact

apotheekswijzen.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SWIJZEN

Warning lights

Financials

What happened to APOTHEEK SWIJZEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions